Sernova Biotherapeutics Inc (ETR:PSH0)
Germany
· Delayed Price · Currency is EUR 0.0800
-0.0195 (-19.60%)
At close: Jun 24, 2025, 5:30 PM CET
Sernova Biotherapeutics Balance Sheet
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 2 | 6.01 | 8.72 | 3.78 | 27.87 | 3.95 | Upgrade
|
| Short-Term Investments | - | - | 11.08 | 46 | - | - | Upgrade
|
| Cash & Short-Term Investments | 2 | 6.01 | 19.81 | 49.78 | 27.87 | 3.95 | Upgrade
|
| Cash Growth | -76.44% | -69.64% | -60.21% | 78.57% | 605.78% | 3.82% | Upgrade
|
| Other Receivables | 0.43 | 0.3 | 1.05 | 1.15 | 0.45 | 0.51 | Upgrade
|
| Receivables | 0.43 | 0.3 | 1.05 | 1.15 | 0.45 | 0.51 | Upgrade
|
| Prepaid Expenses | 0.48 | 0.16 | 0.16 | 0.17 | 0 | 0.15 | Upgrade
|
| Total Current Assets | 2.91 | 6.47 | 21.02 | 51.09 | 28.33 | 4.61 | Upgrade
|
| Property, Plant & Equipment | 0.74 | 0.83 | 0.51 | 0.65 | 0.56 | 0.2 | Upgrade
|
| Other Intangible Assets | - | - | 0.32 | 0.52 | 0.72 | 0.92 | Upgrade
|
| Other Long-Term Assets | 0.22 | 0.22 | 0.26 | 0.22 | 0.21 | - | Upgrade
|
| Total Assets | 3.87 | 7.53 | 22.11 | 52.48 | 29.82 | 5.73 | Upgrade
|
| Accounts Payable | 18.95 | 17.24 | 6.85 | 3.61 | 0.38 | 0.53 | Upgrade
|
| Accrued Expenses | 0.84 | 2.67 | 2.51 | 0.99 | 0.91 | 0.35 | Upgrade
|
| Current Portion of Leases | 0.11 | 0.1 | 0.14 | 0.14 | 0.12 | - | Upgrade
|
| Other Current Liabilities | - | - | 0.1 | - | 0.07 | - | Upgrade
|
| Total Current Liabilities | 23.32 | 20.02 | 9.59 | 4.74 | 1.48 | 0.88 | Upgrade
|
| Long-Term Debt | 0.81 | - | - | - | - | 0.7 | Upgrade
|
| Long-Term Leases | 0.41 | 0.47 | - | 0.14 | 0.28 | - | Upgrade
|
| Total Liabilities | 24.53 | 20.48 | 9.59 | 4.88 | 1.75 | 1.58 | Upgrade
|
| Common Stock | 118.06 | 116.68 | 110.99 | 110.99 | 74.01 | 44.64 | Upgrade
|
| Additional Paid-In Capital | 20.65 | 20.69 | 19.69 | 12.49 | 5.11 | 5.74 | Upgrade
|
| Retained Earnings | -159.83 | -150.36 | -118.17 | -79.17 | -54.75 | -47.78 | Upgrade
|
| Comprehensive Income & Other | 0.45 | 0.03 | - | 3.3 | 3.69 | 1.55 | Upgrade
|
| Shareholders' Equity | -20.66 | -12.96 | 12.51 | 47.61 | 28.07 | 4.14 | Upgrade
|
| Total Liabilities & Equity | 3.87 | 7.53 | 22.11 | 52.48 | 29.82 | 5.73 | Upgrade
|
| Total Debt | 4.74 | 0.57 | 0.14 | 0.28 | 0.39 | 0.7 | Upgrade
|
| Net Cash (Debt) | -2.74 | 5.44 | 19.67 | 49.5 | 27.48 | 3.25 | Upgrade
|
| Net Cash Growth | - | -72.33% | -60.26% | 80.13% | 746.40% | -14.65% | Upgrade
|
| Net Cash Per Share | -0.01 | 0.02 | 0.06 | 0.18 | 0.11 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 328.48 | 328.48 | 303.33 | 303.33 | 262.26 | 231.39 | Upgrade
|
| Total Common Shares Outstanding | 303.41 | 325.32 | 303.33 | 303.33 | 261.13 | 208.26 | Upgrade
|
| Working Capital | -20.41 | -13.55 | 11.43 | 46.35 | 26.85 | 3.73 | Upgrade
|
| Book Value Per Share | -0.07 | -0.04 | 0.04 | 0.16 | 0.11 | 0.02 | Upgrade
|
| Tangible Book Value | -20.66 | -12.96 | 12.2 | 47.09 | 27.35 | 3.23 | Upgrade
|
| Tangible Book Value Per Share | -0.07 | -0.04 | 0.04 | 0.16 | 0.10 | 0.02 | Upgrade
|
| Machinery | - | 0.9 | 0.9 | 0.8 | 0.47 | 0.45 | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.